Cargando…

PRMT6 serves an oncogenic role in lung adenocarcinoma via regulating p18

Lung adenocarcinoma (LUAD), a major subtype of lung cancer, is the leading cause of cancer-related mortality worldwide. Previous studies have determined the role of the protein arginine methyltransferases (PRMTs) in the physiology and pathology of LUAD. However, to the best of our knowledge, no empi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Jie, Meng, Qinge, Shi, Ruirui, Xu, Youqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453511/ https://www.ncbi.nlm.nih.gov/pubmed/32945431 http://dx.doi.org/10.3892/mmr.2020.11402

Ejemplares similares

miR-182-5p Serves as an Oncogene in Lung Adenocarcinoma through Binding to STARD13
por: Wu, Xuhui, et al.
Publicado: (2021)

Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer
por: Almeida-Rios, Diogo, et al.
Publicado: (2016)

TFAP2A Induced ITPKA Serves as an Oncogene and Interacts with DBN1 in Lung Adenocarcinoma
por: Guoren, Zhou, et al.
Publicado: (2020)

Retracted: miR-182-5p Serves as an Oncogene in Lung Adenocarcinoma through Binding to STARD13
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma
por: Wang, Xueying, et al.
Publicado: (2022)

PRMT5: An Emerging Target for Pancreatic Adenocarcinoma
por: Lee, Michael K. C., et al.
Publicado: (2021)

PTPN18 Serves as a Potential Oncogene for Glioblastoma by Enhancing Immune Suppression
por: Wang, Tao, et al.
Publicado: (2023)

PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer
por: Yin, Xin-Ke, et al.
Publicado: (2021)

PRMT1 methylates METTL14 to modulate its oncogenic function
por: Wang, Jingchao, et al.
Publicado: (2023)

The Emerging Role of PRMT6 in Cancer
por: Chen, Zhixian, et al.
Publicado: (2022)

Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6
por: Sivakumaran, Haran, et al.
Publicado: (2013)

Oncogenic RIT1 mutations in lung adenocarcinoma
por: Berger, A H, et al.
Publicado: (2014)

PRMT1 loss sensitizes cells to PRMT5 inhibition
por: Gao, Guozhen, et al.
Publicado: (2019)

Machine Learning for Digital Scoring of PRMT6 in Immunohistochemical Labeled Lung Cancer
por: Mahmoud, Abeer M., et al.
Publicado: (2023)

P3H4 Overexpression Serves as a Prognostic Factor in Lung Adenocarcinoma
por: Jin, Xiangfeng, et al.
Publicado: (2021)

PRMT5 promotes progression of endometrioid adenocarcinoma via ERα and cell cycle signaling pathways
por: Mei, Shuyu, et al.
Publicado: (2021)

Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma
por: Aizemaiti, Rusidanmu, et al.
Publicado: (2021)

An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth
por: Liu, Liu, et al.
Publicado: (2021)

Low expression of PRMT5 in peripheral blood may serve as a potential independent risk factor in assessments of the risk of stable CAD and AMI
por: Tan, Buchuan, et al.
Publicado: (2019)

linc00968 inhibits the tumorigenesis and metastasis of lung adenocarcinoma via serving as a ceRNA against miR-9-5p and increasing CPEB3
por: Tang, Huaping, et al.
Publicado: (2020)

PRMT6-CDC20 facilitates glioblastoma progression via the degradation of CDKN1B
por: Wang, Ji, et al.
Publicado: (2023)

TFAP2A Induced KRT16 as an Oncogene in Lung Adenocarcinoma via EMT
por: Yuanhua, Liu, et al.
Publicado: (2019)

PRMT5-dependent p53 escape in tumorigenesis
por: Li, Yan, et al.
Publicado: (2015)

ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression
por: Wang, Xin, et al.
Publicado: (2016)

MicroRNA-181 serves an oncogenic role in breast cancer via the inhibition of SPRY4
por: Tian, Yifu, et al.
Publicado: (2018)

MicroRNA-181 serves an oncogenic role in breast cancer via the inhibition of SPRY4
por: Tian, Yifu, et al.
Publicado: (2022)

Identification of THSD7B and PRMT9 mutations as risk factors for familial lung adenocarcinoma: A case report
por: Zhang, Qianqian, et al.
Publicado: (2023)

N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker
por: Teng, Yin, et al.
Publicado: (2023)

Combined ARHGEF6 and Tumor Mutational Burden may serve as a potential biomarker for immunotherapy of lung adenocarcinoma
por: Tong, Li, et al.
Publicado: (2023)

p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6
por: Phalke, Sameer, et al.
Publicado: (2012)

Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
por: Niu, Cong, et al.
Publicado: (2022)

Comprehensive identification of microRNA arm selection preference in lung cancer: miR-324-5p and −3p serve oncogenic functions in lung cancer
por: Lin, Min-Hsi, et al.
Publicado: (2018)

The Fanconi anemia pathway controls oncogenic response in hematopoietic stem and progenitor cells by regulating PRMT5-mediated p53 arginine methylation
por: Du, Wei, et al.
Publicado: (2016)

MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma
por: Li, Meng, et al.
Publicado: (2022)

PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma
por: Dong, Feng, et al.
Publicado: (2018)

PRMT5 facilitates angiogenesis and EMT via HIF-1α/VEGFR/Akt signaling axis in lung cancer
por: Zheng, Yonghua, et al.
Publicado: (2023)

Protein arginine methyltransferases PRMT1, PRMT4/CARM1 and PRMT5 have distinct functions in control of osteoblast differentiation
por: Dashti, Parisa, et al.
Publicado: (2023)

BTG2 Serves as a Potential Prognostic Marker and Correlates with Immune Infiltration in Lung Adenocarcinoma
por: Zhang, Xiao Zhen, et al.
Publicado: (2022)

Arginine Methyltransferase PRMT1 Regulates p53 Activity in Breast Cancer
por: Liu, Li-Ming, et al.
Publicado: (2021)

Role of pICLn in Methylation of Sm Proteins by PRMT5
por: Pesiridis, G. Scott, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_eju0dimeqvp18u6fjoaoeka62p